Welfare Reform and Controversial Alzheimer's Drug Rejections

This chapter explores the UK government's proposed welfare reform designed to create a balanced social security system. It also delves into the contentious rejection of two Alzheimer's drugs by NICE, examining the implications for patients and the ongoing debates among experts and pharmaceutical companies.